YCX Stock Overview
Provides life insurance products in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Citizens, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.42 |
| 52 Week High | US$5.30 |
| 52 Week Low | US$1.75 |
| Beta | 0.10 |
| 11 Month Change | 0.91% |
| 3 Month Change | 66.17% |
| 1 Year Change | 41.67% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 133.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| YCX | DE Insurance | DE Market | |
|---|---|---|---|
| 7D | 6.8% | 1.8% | -0.02% |
| 1Y | 41.7% | 22.6% | 8.2% |
Return vs Industry: YCX exceeded the German Insurance industry which returned 22.6% over the past year.
Return vs Market: YCX exceeded the German Market which returned 8.2% over the past year.
Price Volatility
| YCX volatility | |
|---|---|
| YCX Average Weekly Movement | 12.2% |
| Insurance Industry Average Movement | 2.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: YCX's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: YCX's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | 232 | Jon Stenberg | www.citizensinc.com |
Citizens, Inc. provides life insurance products in the United States and internationally. The company operates in two segments, Life Insurance and Home Service Insurance. The Life Insurance segment issues ordinary whole life insurance and endowment policies in the United States dollar-denominated amounts to non-U.S.
Citizens, Inc. Fundamentals Summary
| YCX fundamental statistics | |
|---|---|
| Market cap | €239.63m |
| Earnings (TTM) | €21.16m |
| Revenue (TTM) | €238.52m |
11.3x
P/E Ratio1.0x
P/S RatioIs YCX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YCX income statement (TTM) | |
|---|---|
| Revenue | US$248.38m |
| Cost of Revenue | US$176.61m |
| Gross Profit | US$71.76m |
| Other Expenses | US$49.73m |
| Earnings | US$22.03m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 28.89% |
| Net Profit Margin | 8.87% |
| Debt/Equity Ratio | 0% |
How did YCX perform over the long term?
See historical performance and comparison